Subscribe Become an Author Add Company Sign Up Log In

Infectious Diseases (Bacterial and Viral)

Section: Featured Research     View all sections


New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys

   by Caroline Green    423
New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys

In a new study, researchers from the National Institutes of Health reported that the experimental antiviral drug remdesivir (also known as GS-5734) successfully prevented rhesus monkeys infected with the Middle East Respiratory Syndrome (MERS) coronavirus (MERS-CoV) from becoming ill from this virus infection. Giving remdesivir before infection can prevent them from getting sick, while giving this drug after they are infected can improve their condition. The results were published online February 13, 2020 in the journal PNAS, entitled "Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection".